お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
982382

急性冠症候群治療の世界市場:タイプ別、薬剤別、治療別、診断別、エンドユーザー別の市場調査、展望(~2025年)、COVID-19の累積的な影響

Acute Coronary Syndrome Therapeutic Market Research Report by Type, by Drug, by Treatment, by Diagnosis, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
急性冠症候群治療の世界市場:タイプ別、薬剤別、治療別、診断別、エンドユーザー別の市場調査、展望(~2025年)、COVID-19の累積的な影響
出版日: 2021年02月04日
発行: 360iResearch LLP
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートは、5つの主要通貨(USD、EUR GBP、JPY、AUD)にわたる市場規模と予測を提供します。これは、外貨両替データがすぐに利用できる場合に、組織のリーダーがより良い意思決定を行うのに役立ちます。

1.急性冠症候群治療の市場規模は、2020年の75億8,226万米ドルから、2025年末までに102億5,745万米ドルに成長すると予想されています。

2.急性冠症候群治療の市場規模は、2020年の66億4,826万ユーロから、2025年末までに89億9,393万ユーロに成長すると予想されています。

3.急性冠症候群治療の市場規模は、2020年の59億1,032万ポンドから、2025年末までに79億9,562万ポンドに成長すると予想されています。

4.急性冠症候群治療の市場規模は、2020年の8,092億1,927万円から、2025年末までに1兆947億3,090万円に成長すると予想されています。

5.急性冠症候群治療の市場規模は、2020年の110億1,044万豪ドルから、2025年末までに148億9,519万豪ドルに成長すると予想されています。

市場セグメンテーションとカバレッジ:

この調査レポートは、急性冠症候群治療の世界市場を分類して、収益を予測し、次の各サブマーケットの動向を分析します。

タイプに基づくセグメントでは、急性冠症候群治療市場は、非ST上昇型心筋梗塞、ST上昇型心筋梗塞、およびバイアル不安定狭心症にわたって調査されました。

薬剤に基づくセグメントでは、急性冠症候群治療市場は、降圧薬、抗血栓薬、およびスタチン全体で調査されました。

治療に基づくセグメントでは、急性冠症候群治療市場は、薬物治療、退院後治療、入院前ケア、および再灌流療法にわたって調査されました。薬物治療は、狭心症治療薬、抗凝固薬、および抗血小板薬にわたってさらに調査されました。

診断に基づくセグメントでは、急性冠症候群治療市場は、血液検査、コンピューター断層撮影血管造影、冠動脈造影、心エコー図、およびイメージングにわたって調査されました。

エンドユーザーに基づくセグメントでは、急性冠症候群治療市場は、学術機関、診断センター、および病院と診療所で調査されました。

「アジア太平洋地域は、予測期間中に最高の成長を示すと予測されています」

地域別では、 市場は、南北アメリカ、アジア太平洋、および欧州と中東・アフリカに分けて調査されました。南北アメリカ地域はアルゼンチン、ブラジル、カナダ、メキシコ、および米国。アジア太平洋地域はオーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、韓国、タイ。欧州と中東およびアフリカ地域は、フランス、ドイツ、イタリア、オランダ、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、アラブ首長国連邦、および英国において調査されました。南北アメリカは2020年に急性冠症候群治療市場で最大のサイズを示しました。一方、アジア太平洋地域は予測期間中に最速のCAGRで成長すると予想されます。

企業のユーザビリティプロファイル:

レポートは、AbbVie Inc.、Amgen Inc.、Arena Pharmaceuticals, Inc.、AstraZeneca PLC、 Baxter International Inc.、Bayer AG、 Biogen Inc.、 Boehringer Ingelheim International GmbH、Eli Lilly and Company、Gilead Sciences, Inc.、 Gilead Sciences, Inc.、 GlaxoSmithKline PLC、Johnson & Johnson Services, Inc.、Merck & Co., Inc.、Novartis International AG、Pfizer Inc.、 Teva Pharmaceutical Industries Ltd.、XOMA Corporationなど、世界の急性冠状動脈症候群治療市場における主要ベンダーによる最近の重要な進展とイノベーションプロファイルを深く探求しています。

COVID-19の累積的影響:

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

360iResearch?FPNVポジショニングマトリックス:

360iResearch?FPNVポジショニングマトリックスは、企業がより良い意思決定を行い、競合情勢を理解するのに役立つビジネス戦略(ビジネスの成長、業界のカバレッジ、経済的実行可能性、チャネルサポート)と製品の満足度(コストパフォーマンス、使いやすさ、製品の機能、およびカスタマーサポート)に基づいて、当市場のベンダーを評価および分類します。

360iResearch?コンペティティブ・ストラテジック・ウィンドウ(競争力のある戦略的ウィンドウ):

360iResearch? コンペティティブ・ストラテジック・ウィンドウは、市場、アプリケーション、および地域の観点から競合情勢を分析します。 これはベンダーが将来の成長見通しに対する能力と機会の間の調整または適合を定義するのに役立ちます。予測期間中に、ベンダーが継続的な合併および買収戦略、地域の拡大、研究開発、および新製品の導入戦略を採用して、さらなる事業の拡大と成長を実行するための最適または有利な適合を定義します。

レポートは、次の指針に関する洞察を提供します。

1.市場浸透:主要なプレーヤーにより提供される市場に関する包括的な情報

2.市場開発:収益性の高い新興市場に関する詳細な情報と市場分析

3.市場の多様化:新製品の発売、未開発の地域、最近の開発、および投資に関する詳細情報

4.競争力のある評価とインテリジェンス:主要企業の市場シェア、戦略、製品、製造能力の徹底的な評価

5.製品開発とイノベーション:将来のテクノロジー、R&D活動、および新製品開発に関するインテリジェントな洞察

レポートは次のような質問に答えます。

1.当世界市場の規模と予測はどのようなものですか?

2.予測期間中に市場を形成するCOVID-19の阻害要因と影響は何ですか?

3.予測期間中に投資する製品、セグメント、アプリケーション、領域はどれですか?

4.市場における機会のコンペティティブ・ストラテジック・ウィンドウは何ですか?

5.市場の技術動向と規制の枠組みは何ですか?

6.市場に参入するのに適していると考えられるモードと戦略的動きは何ですか?

当レポートでは急性冠症候群治療の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、タイプ・薬剤・治療・診断・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査のために考慮された年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 医薬品の見通し
  • タイプの見通し
  • 治療の見通し
  • 診断の見通し
  • エンドユーザーの見通し
  • 地域展望
  • 競合他社の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズのファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 タイプ別

  • イントロダクション
  • 非ST上昇型心筋梗塞
  • ST上昇型心筋梗塞
  • バイアル不安定狭心症

第7章 薬剤別

  • イントロダクション
  • 降圧薬
  • 抗血栓剤
  • スタチン

第8章 治療別

  • イントロダクション
  • 薬物治療
    • 抗狭心症薬
    • 抗凝固剤
    • 抗血小板薬
  • 退院後の治療
  • 病院前ケア
  • 再灌流療法

第9章 診断別

  • イントロダクション
  • 血液検査
  • コンピューター断層撮影血管造影
  • 冠動脈造影
  • 心エコー図
  • イメージング

第10章 エンドユーザー別

  • イントロダクション
  • 学術機関
  • 診断センター
  • 病院とクリニック

第11章 南北アメリカ

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第13章 欧州、中東・アフリカ

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第15章 企業のユーザビリティプロファイル

  • AbbVie Inc.
  • Amgen Inc.
  • Arena Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Gilead Sciences, Inc.,
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • XOMA Corporation

第16章 付録

  • ディスカッションガイド
図表

List of Figures

  • FIGURE 1. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 12. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 14. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: MARKET DYNAMICS
  • FIGURE 15. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 16. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
  • FIGURE 17. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2025
  • FIGURE 19. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY NON-ST-ELEVATION MYOCARDIAL INFARCTION, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ST-ELEVATION MYOCARDIAL INFARCTION, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY VIAL UNSTABLE ANGINA, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2020 VS 2025 (%)
  • FIGURE 23. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2025
  • FIGURE 25. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIHYPERTENSIVE, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTITHROMBOTIC, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY STATINS, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
  • FIGURE 29. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2025
  • FIGURE 31. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIANGINAL DRUG, 2020 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTICOAGULANT, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIPLATELET DRUG, 2020 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY POST DISCHARGE TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY PREHOSPITAL CARE, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY REPERFUSION THERAPY, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (%)
  • FIGURE 39. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2025
  • FIGURE 41. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY BLOOD TESTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 42. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY ANGIOGRAM, 2020 VS 2025 (USD MILLION)
  • FIGURE 43. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY CORONARY ANGIOGRAM, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ECHOCARDIOGRAM, 2020 VS 2025 (USD MILLION)
  • FIGURE 45. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY IMAGING, 2020 VS 2025 (USD MILLION)
  • FIGURE 46. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2020 VS 2025 (%)
  • FIGURE 47. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2025
  • FIGURE 49. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ACADEMIC INSTITUTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 50. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 51. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY HOSPITAL & CLINICS, 2020 VS 2025 (USD MILLION)
  • FIGURE 52. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 53. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 55. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 61. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 63. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 75. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 77. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 78. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 79. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 80. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 81. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 82. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 83. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 84. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 85. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 86. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 87. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 88. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY NON-ST-ELEVATION MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ST-ELEVATION MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY VIAL UNSTABLE ANGINA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIHYPERTENSIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTITHROMBOTIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY STATINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG TREATMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIANGINAL DRUG, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTICOAGULANT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIPLATELET DRUG, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY POST DISCHARGE TREATMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY PREHOSPITAL CARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY REPERFUSION THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY BLOOD TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY ANGIOGRAM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY CORONARY ANGIOGRAM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ECHOCARDIOGRAM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY IMAGING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ACADEMIC INSTITUTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 167. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 168. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 169. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 170. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 171. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 172. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 173. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: SCORES
  • TABLE 174. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: BUSINESS STRATEGY
  • TABLE 175. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: PRODUCT SATISFACTION
  • TABLE 176. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RANKING
  • TABLE 177. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: MERGER & ACQUISITION
  • TABLE 178. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 179. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 180. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: INVESTMENT & FUNDING
  • TABLE 181. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 182. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: LICENSE & PRICING
目次
Product Code: MRR-E4D9530

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from USD 7,582.26 Million in 2020 to USD 10,257.45 Million by the end of 2025.

2. The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from EUR 6,648.26 Million in 2020 to EUR 8,993.93 Million by the end of 2025.

3. The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from GBP 5,910.32 Million in 2020 to GBP 7,995.62 Million by the end of 2025.

4. The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from JPY 809,219.27 Million in 2020 to JPY 1,094,730.90 Million by the end of 2025.

5. The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from AUD 11,010.44 Million in 2020 to AUD 14,895.19 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Acute Coronary Syndrome Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Acute Coronary Syndrome Therapeutic Market studied across Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina.

Based on Drug, the Acute Coronary Syndrome Therapeutic Market studied across Antihypertensive, Antithrombotic, and Statins.

Based on Treatment, the Acute Coronary Syndrome Therapeutic Market studied across Drug Treatment, Post Discharge Treatment, Prehospital Care, and Reperfusion Therapy. The Drug Treatment further studied across Antianginal Drug, Anticoagulant, and Antiplatelet Drug.

Based on Diagnosis, the Acute Coronary Syndrome Therapeutic Market studied across Blood Tests, Computerized Tomography Angiogram, Coronary Angiogram, Echocardiogram, and Imaging.

Based on End User, the Acute Coronary Syndrome Therapeutic Market studied across Academic Institutes, Diagnostic Centers, and Hospital & Clinics.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Acute Coronary Syndrome Therapeutic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Acute Coronary Syndrome Therapeutic Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Acute Coronary Syndrome Therapeutic Market including AbbVie Inc., Amgen Inc., Arena Pharmaceuticals, Inc., AstraZeneca PLC, Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Company, Gilead Sciences, Inc., Gilead Sciences, Inc.,, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and XOMA Corporation.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Acute Coronary Syndrome Therapeutic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Acute Coronary Syndrome Therapeutic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acute Coronary Syndrome Therapeutic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acute Coronary Syndrome Therapeutic Market?

4. What is the competitive strategic window for opportunities in the Global Acute Coronary Syndrome Therapeutic Market?

5. What are the technology trends and regulatory frameworks in the Global Acute Coronary Syndrome Therapeutic Market?

6. What are the modes and strategic moves considered suitable for entering the Global Acute Coronary Syndrome Therapeutic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Outlook
  • 3.4. Type Outlook
  • 3.5. Treatment Outlook
  • 3.6. Diagnosis Outlook
  • 3.7. End User Outlook
  • 3.8. Geography Outlook
  • 3.9. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased cases of atherosclerosis (myocardial infarction) and unstable angina
      • 5.1.1.2. Growing aging population and poor immune systems
      • 5.1.1.3. Increased pharmaceutical R&D investment and introduction of innovative drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Obstruction due to less number of approved drugs for the treatment of acute coronary syndrome
    • 5.1.3. Opportunities
      • 5.1.3.1. Reperfusion of the myocardium and prevent reinfarction in order to promote patient survival
      • 5.1.3.2. Extensive pipeline drugs with properties, such as high patient compliance and improved safety
      • 5.1.3.3. Improving health care infrastructure and government reimbursement programs
    • 5.1.4. Challenges
      • 5.1.4.1. Cost and formulation
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Acute Coronary Syndrome Therapeutic Market, By Type

  • 6.1. Introduction
  • 6.2. Non-ST-elevation Myocardial Infarction
  • 6.3. ST-elevation Myocardial Infarction
  • 6.4. Vial Unstable Angina

7. Global Acute Coronary Syndrome Therapeutic Market, By Drug

  • 7.1. Introduction
  • 7.2. Antihypertensive
  • 7.3. Antithrombotic
  • 7.4. Statins

8. Global Acute Coronary Syndrome Therapeutic Market, By Treatment

  • 8.1. Introduction
  • 8.2. Drug Treatment
    • 8.2.1. Antianginal Drug
    • 8.2.2. Anticoagulant
    • 8.2.3. Antiplatelet Drug
  • 8.3. Post Discharge Treatment
  • 8.4. Prehospital Care
  • 8.5. Reperfusion Therapy

9. Global Acute Coronary Syndrome Therapeutic Market, By Diagnosis

  • 9.1. Introduction
  • 9.2. Blood Tests
  • 9.3. Computerized Tomography Angiogram
  • 9.4. Coronary Angiogram
  • 9.5. Echocardiogram
  • 9.6. Imaging

10. Global Acute Coronary Syndrome Therapeutic Market, By End User

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Diagnostic Centers
  • 10.4. Hospital & Clinics

11. Americas Acute Coronary Syndrome Therapeutic Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Acute Coronary Syndrome Therapeutic Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. South Korea
  • 12.10. Thailand

13. Europe, Middle East & Africa Acute Coronary Syndrome Therapeutic Market

  • 13.1. Introduction
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Netherlands
  • 13.6. Qatar
  • 13.7. Russia
  • 13.8. Saudi Arabia
  • 13.9. South Africa
  • 13.10. Spain
  • 13.11. United Arab Emirates
  • 13.12. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis
  • 14.3. Market Share Analysis
  • 14.4. Competitor SWOT Analysis
  • 14.5. Competitive Scenario
    • 14.5.1. Merger & Acquisition
    • 14.5.2. Agreement, Collaboration, & Partnership
    • 14.5.3. New Product Launch & Enhancement
    • 14.5.4. Investment & Funding
    • 14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. AbbVie Inc.
  • 15.2. Amgen Inc.
  • 15.3. Arena Pharmaceuticals, Inc.
  • 15.4. AstraZeneca PLC
  • 15.5. Baxter International Inc.
  • 15.6. Bayer AG
  • 15.7. Biogen Inc.
  • 15.8. Boehringer Ingelheim International GmbH
  • 15.9. Eli Lilly and Company
  • 15.10. Gilead Sciences, Inc.
  • 15.11. Gilead Sciences, Inc.,
  • 15.12. GlaxoSmithKline PLC
  • 15.13. Johnson & Johnson Services, Inc.
  • 15.14. Merck & Co., Inc.
  • 15.15. Novartis International AG
  • 15.16. Pfizer Inc.
  • 15.17. Teva Pharmaceutical Industries Ltd.
  • 15.18. XOMA Corporation

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.